Partnering for success: Tools and resources shaping urology practices in 2026
By SPN
As urology practices grapple with a complex and evolving healthcare landscape, they need a strategic partner to help them streamline operations and workflows and optimize patient care and safety. Cencora recently hosted a webinar to demonstrate how our urology solutions portfolio can support the workflows and business priorities or urology practices – including analytics tools, inventory management, and GPO membership opportunities.
Below is an overview of Cencora’s expanding portfolio of solutions designed to strengthen practice performance, support clinical excellence, and prepare urology practices for the realities of 2026 and beyond.
Centralize inventory and workflow with Nucleus®
At the heart of Cencora’s solutions is Nucleus, the inventory management solution designed to support ordering processes and billing workflows. Practices rely on Nucleus not only to track and manage high-value biologics, but also to streamline procurement, reduce carrying costs, and maintain visibility across multiple locations. The platform’s ability to integrate with practice management systems and EMRs gives providers a clearer picture of what they are administering, how it aligns with patient history, and where discrepancies may exist. With nearly 1,000 active users and close to 6 million treatments logged over the last 12 months, Nucleus is the core of everything that happens around drug distribution and inventory management at the practice level. From reducing administrative burden and carrying costs and streamlining procurement to elevating patient satisfaction and unlocking data insights, Nucleus helps practices operate more efficiently while prioritizing patient care.
Optional features – such as Witness, which adds a second layer of verification for controlled substances – reinforce compliance and reduce risk. And because Nucleus is browser-based and supported by optional hardware configurations, practices can tailor the system to their storage, dispensing, and security needs without disrupting established workflows.
Optimize infusion management with IntelliDoseTxM®
IntelliDoseTxM is Cencora’s comprehensive infusion management solution that integrates directly with Nucleus. The platform simplifies regimen selection, scheduling, and charting while embedding clinical decision support to reduce the risk of dosing errors. As treatments are administered, IntelliDoseTxM captures the details needed for accurate billing and seamlessly connects back to Nucleus and the practice’s EMR. The result is a more complete, more reliable record of what was given, why it was given, and how it should be billed – an essential safeguard in a high-risk, high-complexity environment.
Identify areas for operational improvement with InfoDive®
In addition to creating operational efficiency, practices need visibility into their financial performance. InfoDive, Cencora’s business intelligence platform, brings these insights together by combining practice management data with Medicare claims, inventory dispenses, census information, GPO rebate data and relative value units (RVUs).
The result is a reporting engine that helps practices understand how they are performing internally and against their peers. Cencora has also coordinated data with LUGPA to provide benchmarking so that urology practices can understand how they stack up against other practices within the organization based on a wide range of financial data. Additionally, InfoDive supports advocacy efforts by contributing anonymized data to help LUGPA evaluate policy changes and represent the interest of independent urology practices.
Navigate the regulatory environment with MIPS Consulting Services
Regulatory programs continue to evolve, and many practices struggle to keep pace – especially when staff turnover threatens to disrupt institutional knowledge. Cencora’s MIPS Consulting services team has spent more than 16 years guiding practices through program changes, reporting requirements, and performance optimization for Medicare reporting requirements.
Rather than relying on a single internal “MIPS person,” practices gain a partner who monitors annual updates, evaluates measure performance, and helps capture incentives and avoid penalties. Renewal rates remain high because the service removes a significant administrative burden while protecting revenue that practices cannot afford to lose.
Expand access through Specialty Practice Rx Services
As medically integrated dispensing (MID) expands within urology, Cencora’s Specialty Practice Rx Services provides the infrastructure, analytics, and field support needed to build or optimize a program. With two decades of MID experience, the Cencora team helps practices evaluate prescription patterns, assess reimbursement potential, and determine whether MID is the right strategic fit.
Once a program is underway, Cencora supports everything from staffing guidance to Pharmacy Services Administrative Organization (PSAO) contracting, workflow design, accreditation preparation, and ongoing optimization. Practices gain a clearer understanding of capture rates, limited-distribution products, and reimbursement trends – allowing them to retain more prescriptions in-house while improving continuity of care.
Advocate for community urology practices with Community Counts
One of the most overlooked but essential components of Cencora’s support model is Community Counts. As legislative agendas shift at both the federal and state levels, Community Counts helps independent urology practices have representation in policy discussions that affect reimbursement, access, and the sustainability of community-based care.
Align purchasing and strategy with GPO support
Through Cencora’s Specialty Practice Network (SPN), practices gain access to GPO contracting, technology implementation support, educational opportunities, and a dedicated team that manages contracts year-round. SPN’s real-time analytics help practices evaluate contract economics, anticipate quarterly shifts, and determine whether switching products makes financial sense.
Advanced ROI modeling supports decisions around specific drugs, providing deeper insights into purchasing decisions.
Looking ahead: Support for theranostics and radiopharmaceuticals
As the theranostics and radiopharmaceuticals market expands, Cencora will offer best-in-class GPO contracts on key PSMA imaging agents and therapeutics within the radioligand therapy space. Our team will help equip practices with the most competitive offering and access to essential products for patient care. As we look to 2027, we will be building out education-driven opportunities, including web series, podcasts, and virtual meetings designed to educate urology practices on this specialized offering.
Additionally, Cencora is advancing its role as the exclusive GPO dedicated to providing comprehensive turnkey solutions in the field of nuclear medicine and radiopharmaceuticals to help practices expand and thrive. From enhancing clinical research, building a hot lab, developing a theranostics program, or integrating radiation oncology services in-house, Cencora is well-positioned to support urology practices achieve these objectives without capital investment, operational complexity, or financial risk.
For more information, you can access the webinar here
At the heart of Cencora’s solutions is Nucleus, the inventory management solution designed to support ordering processes and billing workflows. Practices rely on Nucleus not only to track and manage high-value biologics, but also to streamline procurement, reduce carrying costs, and maintain visibility across multiple locations. The platform’s ability to integrate with practice management systems and EMRs gives providers a clearer picture of what they are administering, how it aligns with patient history, and where discrepancies may exist. With nearly 1,000 active users and close to 6 million treatments logged over the last 12 months, Nucleus is the core of everything that happens around drug distribution and inventory management at the practice level. From reducing administrative burden and carrying costs and streamlining procurement to elevating patient satisfaction and unlocking data insights, Nucleus helps practices operate more efficiently while prioritizing patient care.
Optional features – such as Witness, which adds a second layer of verification for controlled substances – reinforce compliance and reduce risk. And because Nucleus is browser-based and supported by optional hardware configurations, practices can tailor the system to their storage, dispensing, and security needs without disrupting established workflows.
Optimize infusion management with IntelliDoseTxM®
IntelliDoseTxM is Cencora’s comprehensive infusion management solution that integrates directly with Nucleus. The platform simplifies regimen selection, scheduling, and charting while embedding clinical decision support to reduce the risk of dosing errors. As treatments are administered, IntelliDoseTxM captures the details needed for accurate billing and seamlessly connects back to Nucleus and the practice’s EMR. The result is a more complete, more reliable record of what was given, why it was given, and how it should be billed – an essential safeguard in a high-risk, high-complexity environment.
Identify areas for operational improvement with InfoDive®
In addition to creating operational efficiency, practices need visibility into their financial performance. InfoDive, Cencora’s business intelligence platform, brings these insights together by combining practice management data with Medicare claims, inventory dispenses, census information, GPO rebate data and relative value units (RVUs).
The result is a reporting engine that helps practices understand how they are performing internally and against their peers. Cencora has also coordinated data with LUGPA to provide benchmarking so that urology practices can understand how they stack up against other practices within the organization based on a wide range of financial data. Additionally, InfoDive supports advocacy efforts by contributing anonymized data to help LUGPA evaluate policy changes and represent the interest of independent urology practices.
Navigate the regulatory environment with MIPS Consulting Services
Regulatory programs continue to evolve, and many practices struggle to keep pace – especially when staff turnover threatens to disrupt institutional knowledge. Cencora’s MIPS Consulting services team has spent more than 16 years guiding practices through program changes, reporting requirements, and performance optimization for Medicare reporting requirements.
Rather than relying on a single internal “MIPS person,” practices gain a partner who monitors annual updates, evaluates measure performance, and helps capture incentives and avoid penalties. Renewal rates remain high because the service removes a significant administrative burden while protecting revenue that practices cannot afford to lose.
Expand access through Specialty Practice Rx Services
As medically integrated dispensing (MID) expands within urology, Cencora’s Specialty Practice Rx Services provides the infrastructure, analytics, and field support needed to build or optimize a program. With two decades of MID experience, the Cencora team helps practices evaluate prescription patterns, assess reimbursement potential, and determine whether MID is the right strategic fit.
Once a program is underway, Cencora supports everything from staffing guidance to Pharmacy Services Administrative Organization (PSAO) contracting, workflow design, accreditation preparation, and ongoing optimization. Practices gain a clearer understanding of capture rates, limited-distribution products, and reimbursement trends – allowing them to retain more prescriptions in-house while improving continuity of care.
Advocate for community urology practices with Community Counts
One of the most overlooked but essential components of Cencora’s support model is Community Counts. As legislative agendas shift at both the federal and state levels, Community Counts helps independent urology practices have representation in policy discussions that affect reimbursement, access, and the sustainability of community-based care.
Align purchasing and strategy with GPO support
Through Cencora’s Specialty Practice Network (SPN), practices gain access to GPO contracting, technology implementation support, educational opportunities, and a dedicated team that manages contracts year-round. SPN’s real-time analytics help practices evaluate contract economics, anticipate quarterly shifts, and determine whether switching products makes financial sense.
Advanced ROI modeling supports decisions around specific drugs, providing deeper insights into purchasing decisions.
Looking ahead: Support for theranostics and radiopharmaceuticals
As the theranostics and radiopharmaceuticals market expands, Cencora will offer best-in-class GPO contracts on key PSMA imaging agents and therapeutics within the radioligand therapy space. Our team will help equip practices with the most competitive offering and access to essential products for patient care. As we look to 2027, we will be building out education-driven opportunities, including web series, podcasts, and virtual meetings designed to educate urology practices on this specialized offering.
Additionally, Cencora is advancing its role as the exclusive GPO dedicated to providing comprehensive turnkey solutions in the field of nuclear medicine and radiopharmaceuticals to help practices expand and thrive. From enhancing clinical research, building a hot lab, developing a theranostics program, or integrating radiation oncology services in-house, Cencora is well-positioned to support urology practices achieve these objectives without capital investment, operational complexity, or financial risk.
For more information, you can access the webinar here
